Epirubicin plus paclitaxel versus cyclophosphamide, epirubicin and 5-fluorouracil as adjuvant treatment of node positive breast cancer patients: a controlled randomized phase III study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Epirubicin; Fluorouracil; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 18 Dec 2013 Biomarkers information updated
- 28 Sep 2005 New trial record.